{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"apolipoprotein-c-iii-deficiency","columns":[{"gene":"","key":"population-e77465fd546593639782","label":"Hyperalphalipoproteinemia 2","mondoId":"MONDO:0013534","onsetQualifier":null,"originColumnKey":"MONDO:0013534/OMIM:614028","originalViews":[{"key":"MONDO:0013534/OMIM:614028","label":"Hyperalphalipoproteinemia 2","scopeLabel":"OMIM:614028","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0af373c84a2441ff30894ff37d102794077dc59f3ea18a557740eac7166e520f","6dd605e7ac27a5684b4856ac6ec48bd19dd793dd424966281c2774a97e6007d6","840a15f0aa60b8ed4672b39c8db0c7481b970059c945f3905d581a9609dd639c"],"recordQualifiers":{},"scopeLabel":"OMIM:614028","sourceIds":["OMIM:614028"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-e77465fd546593639782"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003563","HP:0012184","HP:0012153"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":3,"sourceGroups":{"published":3}},"features":[{"hpoId":"HP:0003563","label":"Decreased circulating LDL-C concentration","primary":true},{"hpoId":"HP:0012184","label":"Elevated circulating HDL-C concentration","primary":true},{"hpoId":"HP:0012153","label":"Hypotriglyceridemia","primary":true}],"ledeHtml":"","mondoId":"MONDO:0013534","node":{"canonicalSlug":"apolipoprotein-c-iii-deficiency","comparisons":[{"documentSha256":"b0b80d8ac63510bdc39797872dbff20799e25153669c09e410b3578b69a201c7","key":"legacy-apolipoprotein-c-iii-deficiency","kind":"legacy","label":"apolipoprotein c-III deficiency","memberIds":["MONDO:0013534"],"mondoId":"MONDO:0013534","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/apolipoprotein-c-iii-deficiency.b0b80d8ac63510bdc39797872dbff20799e25153669c09e410b3578b69a201c7.json"}],"contexts":[],"lifecycle":"active","narrative":null,"ownColumnKeys":["population-e77465fd546593639782"],"publication":"published","relationships":[{"kind":"parent","label":"inborn errors of metabolism","mondoId":"MONDO:0019052","slug":"inborn-errors-of-metabolism"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/18076"}],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"0af373c84a2441ff30894ff37d102794077dc59f3ea18a557740eac7166e520f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614028","disease_name":"Hyperalphalipoproteinemia 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003563","is_excluded":false,"label":"Decreased circulating LDL-C concentration","onset_id":null,"reference":"PMID:19074352","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"6dd605e7ac27a5684b4856ac6ec48bd19dd793dd424966281c2774a97e6007d6","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614028","disease_name":"Hyperalphalipoproteinemia 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0012184","is_excluded":false,"label":"Elevated circulating HDL-C concentration","onset_id":null,"reference":"PMID:19074352","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"840a15f0aa60b8ed4672b39c8db0c7481b970059c945f3905d581a9609dd639c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614028","disease_name":"Hyperalphalipoproteinemia 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0012153","is_excluded":false,"label":"Hypotriglyceridemia","onset_id":null,"reference":"PMID:19074352","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[],"sharedSources":[],"slug":"apolipoprotein-c-iii-deficiency","sourceDocuments":[],"sourceNote":"","synonyms":["apolipoprotein c-III deficiency"],"takeawayHtml":"","title":"apolipoprotein c-III deficiency"},"schemaVersion":1}
